The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
G1 Therapeutics, Inc(NASDAQ:GTHX) 
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult ...
Website: http://www.g1therapeutics.com
Founded: 2008
Full Time Employees: 104
Sector: Healthcare
Industry: Biotechnology
G1 Therapeutics Days Payable Outstanding ttm (DPO)
G1 Therapeutics Days Receivable Outstanding ttm (DSO)
G1 Therapeutics Days Inventory Outstanding ttm (DIO)
G1 Therapeutics Op Cashflow Per Share ttm
G1 Therapeutics Free Cashflow Per Share ttm
G1 Therapeutics Cash Per Share ttm
G1 Therapeutics P/S ratio ttm
G1 Therapeutics (GAAP) P/E ratio ttm
G1 Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.